Sign in
4

Changes in Ownership

TENAX THERAPEUTICS, INC. Filed Acc 0001354488-13-006458

Chief Executive Officer acquired 349,959 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kelley John P · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2013-11-13 Grant or award : show line 1 in the form +341,711 341,711 D
2013-11-13 Grant or award : show line 2 in the form +8,248 8,248 D
Loading xslF345X03/issuerdirect_section16.xml…